Safety, Tolerability and Immunogenicity of Gam-COVID-Vac Vaccine in a Nasal Spray

NCT05248373 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
400
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation